Platt FM - Search Results

1

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.

Hurst CD, Cheng G, Platt FM, Castro MAA, Marzouka NS, Eriksson P, Black EVI, Alder O, Lawson ARJ, Lindskrog SV, Burns JE, Jain S, Roulson JA, Brown JC, Koster J, Robertson AG, Martincorena I, Dyrskjøt L, Höglund M, Knowles MA. Hurst CD, et al. Among authors: platt fm. Cell Rep Med. 2021 Dec 21;2(12):100472. doi: 10.1016/j.xcrm.2021.100472. eCollection 2021 Dec 21. Cell Rep Med. 2021. PMID: 35028613 Free PMC article.

2

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA. Hurst CD, et al. Among authors: platt fm. Oncogene. 2008 Apr 24;27(19):2716-27. doi: 10.1038/sj.onc.1210934. Epub 2007 Nov 26. Oncogene. 2008. PMID: 18037967 Free PMC article.

3

Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Pymar LS, Platt FM, Askham JM, Morrison EE, Knowles MA. Pymar LS, et al. Among authors: platt fm. Hum Mol Genet. 2008 Jul 1;17(13):2006-17. doi: 10.1093/hmg/ddn098. Epub 2008 Apr 7. Hum Mol Genet. 2008. PMID: 18397877 Free PMC article.

4

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.

Bentley J, L'Hôte C, Platt F, Hurst CD, Lowery J, Taylor C, Sak SC, Harnden P, Knowles MA, Kiltie AE. Bentley J, et al. Genes Chromosomes Cancer. 2009 Apr;48(4):310-21. doi: 10.1002/gcc.20641. Genes Chromosomes Cancer. 2009. PMID: 19105236

5

Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).

Chapman EJ, Williams SV, Platt FM, Hurst CD, Chambers P, Roberts P, Knowles MA. Chapman EJ, et al. Among authors: platt fm. Genes Chromosomes Cancer. 2009 Aug;48(8):694-710. doi: 10.1002/gcc.20672. Genes Chromosomes Cancer. 2009. PMID: 19405089

6

Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.

Platt FM, Hurst CD, Taylor CF, Gregory WM, Harnden P, Knowles MA. Platt FM, et al. Clin Cancer Res. 2009 Oct 1;15(19):6008-17. doi: 10.1158/1078-0432.CCR-09-0898. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789314

7

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K.

Askham JM, Platt F, Chambers PA, Snowden H, Taylor CF, Knowles MA. Askham JM, et al. Oncogene. 2010 Jan 7;29(1):150-5. doi: 10.1038/onc.2009.315. Epub 2009 Oct 5. Oncogene. 2010. PMID: 19802009

8

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Knowles MA, Platt FM, Ross RL, Hurst CD. Knowles MA, et al. Among authors: platt fm. Cancer Metastasis Rev. 2009 Dec;28(3-4):305-16. doi: 10.1007/s10555-009-9198-3. Cancer Metastasis Rev. 2009. PMID: 20013032 Free PMC article. Review.

9

High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.

Williams SV, Platt FM, Hurst CD, Aveyard JS, Taylor CF, Pole JC, Garcia MJ, Knowles MA. Williams SV, et al. Among authors: platt fm. Genes Chromosomes Cancer. 2010 Jul;49(7):642-59. doi: 10.1002/gcc.20775. Genes Chromosomes Cancer. 2010. PMID: 20461757

10

Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.

Hurst CD, Platt FM, Taylor CF, Knowles MA. Hurst CD, et al. Among authors: platt fm. Clin Cancer Res. 2012 Nov 1;18(21):5865-5877. doi: 10.1158/1078-0432.CCR-12-1807. Epub 2012 Aug 29. Clin Cancer Res. 2012. PMID: 22932667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page